Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „ledipasvir“
Suchtreffer
Begriffe & Kennungen
Biktarvy · 4.5 · Ledipasvir: AUC: ↔ Cmin: ↔ Cmax: ↔
Eintrag öffnenDelstrigo · 4.5 · ledipasvir AUC 0.92 (0.80, 1.06) Patients receiving Cmax 0.91 (0.80, 1.02) doravirine/lamivudine/tenofovirdi l
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Krka · 4.5 · Ledipasvir: AUC: ↔ Cmax: ↔ Cmin: ↔
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Mylan · 4.5 · Ledipasvir: AUC: ↔ Cmax: ↔ Cmin: ↔
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Mylan · 4.5 · NC = not calculated N/A = not applicable. 1 Data generated from simultaneous dosing with ledipasvir/sofosbuvir
Eintrag öffnenEviplera · 4.5 · Tenofovir: AUC: ↓ 10% C12h: ↓ 13% Cmax: ↓ 23% Other antiviral agents Ledipasvir/Sofosbuvir Ledipasvir: No dose
Eintrag öffnenHarvoni · 4.5 · (Increase in gastric pH) H2-receptor antagonists Famotidine Ledipasvir H2-receptor antagonists may be administ
Eintrag öffnenHarvoni · 4.5 · (Increase in gastric pH) H2-receptor antagonists Famotidine Ledipasvir H2-receptor antagonists may be administ
Eintrag öffnenHarvoni · 4.5 · (Increase in gastric pH) Proton pump inhibitors Omeprazole Ledipasvir Proton pump inhibitor doses comparable t
Eintrag öffnenHarvoni · 4.5 · (Increase in gastric pH) Proton pump inhibitors Omeprazole Ledipasvir Proton pump inhibitor doses comparable t
Eintrag öffnenHarvoni · 4.5 · As Harvoni contains ledipasvir and sofosbuvir, any interactions that have been identified with these active su
Eintrag öffnenHarvoni · 4.5 · As Harvoni contains ledipasvir and sofosbuvir, any interactions that have been identified with these active su
Eintrag öffnenHarvoni · 4.5 · Ledipasvir (90 mg once Midazolam daily) ↔ Cmax 0.95 (0.87, 1.04) ↔ AUC 0.89 (0.84, 0.95) (Induction of CYP3A)
Eintrag öffnenHarvoni · 4.5 · Ledipasvir (90 mg once Midazolam daily) ↔ Cmax 0.95 (0.87, 1.04) ↔ AUC 0.89 (0.84, 0.95) (Induction of CYP3A)
Eintrag öffnenHarvoni · 4.5 · Ledipasvir and sofosbuvir are substrates of drug transporter P-gp and BCRP while GS-331007 is not.
Eintrag öffnenHarvoni · 4.5 · Ledipasvir and sofosbuvir are substrates of drug transporter P-gp and BCRP while GS-331007 is not.
Eintrag öffnenHarvoni · 4.5 · Ledipasvir is an in vitro inhibitor of drug transporter P-gp and breast cancer resistance protein (BCRP) and m
Eintrag öffnenHarvoni · 4.5 · Ledipasvir is an in vitro inhibitor of drug transporter P-gp and breast cancer resistance protein (BCRP) and m
Eintrag öffnenHarvoni · 4.5 · Ledipasvir ↑ Cmax 1.63 (1.51, 1.75) ↑ AUC 1.78 (1.64, 1.94) ↑ Cmin 1.91 (1.76, 2.08)
Eintrag öffnenHarvoni · 4.5 · Ledipasvir ↑ Cmax 1.63 (1.51, 1.75) ↑ AUC 1.78 (1.64, 1.94) ↑ Cmin 1.91 (1.76, 2.08)
Eintrag öffnen